Default Category
-
Shakey’s Initial Public Offering: The Dilemma of Investing
Maria Theresa Manalac; Stefanie Mae Margaret Jakosalem; Sandeep PuriCase IVEY-9B19N021-EFinance, StrategyIn early December 2016, a student member of the Philippine Fund of the finance lab at the Asian Institute of Management was wondering whether to invest in the initial public offering (IPO) of Shakey’s Pizza Asia Ventures Inc. (Shakey’s). Shakey’s was theStarting at €8.20
-
The Holcim Acquisition: Cementing SMC’s Leadership in the Philippines
Maria Theresa Manalac; Yusoph Maute; Sandeep PuriCase IVEY-9B21N006-EFinanceIn May 2019, a retail investor in the Philippines had to decide whether or not to immediately sell his shares in Holcim Philippines, Inc (HPI). The San Miguel Corporation had just announced the acquisition of around 86 per cent controlling interest in HPI. The price of HPI had increased considerably in the months leading up to the acquisition announcement, and this investor was anticipating a large gain. Now, he needed to run a fair value estimat...Starting at €8.20
-
Embrace (B): Opportunity Assessment
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M005-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part B of a four-part series, which also includes 9B13M004, 9B13M006 and 9B13M007.Starting at €5.74
-
Embrace (C): Competing with Incumbents
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M006-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part C of a four-part series, which also includes 9B13M004, 9B13M005 and 9B13M007.Starting at €5.74
-
Oral Insulin: Breakthrough Innovation at Biocon
Nita Sachan; Prasad Kaipa; Anand Nandkumar; Charles DhanarajCase IVEY-9B11M065-EEntrepreneurship, Service and Operations Management, StrategyThis case deals with the innovation challenges of a medium-sized firm (under $1 billion) in an emerging economy (India), particularly the challenges of product development and commercialization. The management has to decide how to proceed with a promising novel formula for oral insulin — promising both in terms of financial returns as well as social impact. The company has spent several years of research and development in getting the drug throug...Starting at €8.20
-
Customer Management at Magellan Savings Bank Of Philippines
Sandeep Puri; Maria Theresa Manalac; Jayanthi RanjanCase IVEY-9B20A038-EMarketing, StrategyIn June 2019, a newly promoted branch manager of a bank in Davao City, Philippines, must recommend to the bank’s head office who among six loan applicants will obtain loans from the branch. She has received applications for ₱24 million in loans but can only grant ₱18 million. The branch manager needs to (a) decide how much to loan and to which customers, (b) find ways to retain valuable customers and acquire new ones, and (c) consider new avenues...Starting at €8.20
-
D.M. Wenceslao and Associates Incorporated Initial Public Offering
Maria Theresa Manalac; Gian Carlo Lim; Sandeep PuriCase IVEY-9B20N025-EFinance, StrategyOn June 11, 2018, Jake Veluz, portfolio manager at BDO Asset Management had to decide whether or not to invest in the initial public offering (IPO) of D.M. Wenceslao and Associates (DMW), a Philippine-based integrated property developer. The IPO price ofStarting at €8.20
-
Centre for Cellular and Molecular Biology: The Commercialization Challenge
Nita Sachan; Prasad Vemuri; Anand Nandkumar; Charles DhanarajCase IVEY-9B11M064-ECorporate Governance, StrategyThis case deals with the commercialization challenges that a premier research institute in an emerging economy faces despite conducting cutting-edge research. The case is set in 2009 in Hyderabad, India, soon after the appointment of CCMB’s new director, Dr. Mohan Rao. Rao has to decide how to proceed with incentivizing the scientists to find potential applications for their research when most scientists are merely interested in doing basic resea...Starting at €8.20
-
Novartis in India: Innovation versus Affordability
Anand Nandkumar; Charles Dhanaraj; Mridula AnandCase IVEY-9B12M111-EStrategyThis case presents complex managerial challenges that stem from the institutional context in emerging markets, particularly in relation to the intellectual property regime and its impact on business strategy. The case centres around a multinational pharmaceutical firm, Novartis International AG (Novartis), that is waiting on a major court decision regarding patent policy as it pertains to one of the firm’s products. The case takes students throug...Starting at €8.20
-
Embrace (D): Building the Business Model
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M007-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part D of a four-part series, which also includes 9B13M004, 9B13M005 and 9B13M006.Starting at €5.74